# TAZAROTENE
> **ANDA214560** · Abbreviated New Drug Application (Generic) · Sponsor: SOLARIS PHARMA CORP · Approved 2025-11-24
## Drug
- **FDA Application Number:** ANDA214560
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TAZAROTENE
- **Generic name:** Tazarotene
- **Active ingredients:** TAZAROTENE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** SOLARIS PHARMA CORP
- **First approval:** 2025-11-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214560)
---
*AI Analytics · CC0 1.0*